FDA Approves Wider Humira Use Despite Efficacy Concerns
According to the FDA’s statement, the drug has been approved to treat moderate to severe ulcerative colitis in patients for whom immunosuppressant medicines — the traditional treatment for the condition — have not worked, following two successful Phase III clinical studies.
Colitis, which causes inflammation and ulcers...
Already a subscriber? Click here to login